Similarly, Ali and colleagues showed that in vitro killing of h5T4-expressing tumour cells by h5T4-reactive splenocytes was completely abrogated by incubation of the splenocytes with CD8-specific antibody prior to the assay. Here, CD8A is linked to neoplasm.